Lincoln Pharmaceuticals Ltd vs Smruthi Organics Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Lincoln Pharmaceuticals Ltd is ₹ 618 as of 17 Feb 16:01 . The P/E Ratio of Lincoln Pharmaceuticals Ltd changed from 7.2 on March 2021 to 13.4 on March 2025 . This represents a CAGR of 13.23% over 5 yearsThe P/E Ratio of Smruthi Organics Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Lincoln Pharmaceuticals Ltd changed from ₹ 449.4 crore on March 2021 to ₹ 1104 crore on March 2025 . This represents a CAGR of 19.71% over 5 yearsThe Market Cap of Smruthi Organics Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Lincoln Pharmaceuticals Ltd for the Dec '25 is ₹ 181.47 crore as compare to the Sep '25 revenue of ₹ 170.6 crore. This represent the growth of 6.37% The revenue of Smruthi Organics Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Lincoln Pharmaceuticals Ltd for the Dec '25 is ₹ 38.74 crore as compare to the Sep '25 ebitda of ₹ 32.66 crore. This represent the growth of 18.62% The ebitda of Smruthi Organics Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Lincoln Pharmaceuticals Ltd changed from ₹ 23.67 crore to ₹ 28.6 crore over 7 quarters. This represents a CAGR of 11.42% The net profit of Smruthi Organics Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Lincoln Pharmaceuticals Ltd changed from 4.83 % on March 2021 to 4.38 % on March 2025 . This represents a CAGR of -1.94% over 5 yearsThe Dividend Payout of Smruthi Organics Ltd changed from 20.08 % on March 2021 to 48.24 % on March 2025 . This represents a CAGR of 19.16% over 5 years .

About Lincoln Pharmaceuticals Ltd

Lincoln Pharmaceuticals Limited, promoted by Mahendra G Patel, Rajnikant G Patel and Hasmukhbhai I Patel, as a Partnership Firm in January, 1979 to manufacture pharmaceutical formulations was converted into a Public Limited Company in Jan. '95.
All the assets and business of the erstwhile partnership were transferred to the Company.
The Company is engaged in the business of manufacturing and trading of pharmaceutical products.
The focused area includes anti-infective, respiratory system, gynecology, cardio & CNS, anti-diabetic, anti malaria, among others. The Company, incorporated in January, 1995, was carrying on its business by getting its products manufactured on loan licence basis from 1979 to 1982.
It then set up its own manufacturing facilities at Naroda, Gujarat for manufacturing tablets, capsules, liquid and powder syrups and, ointments.

About Smruthi Organics Ltd

Smruthi Organics Limited was incorporated in July, 1989 as a Private Limited Company and was subsequently converted into a Public Limited Company in February, 1995.
The Company was promoted by E Purushotham and Shankarrao R Myakal.
The Company is a manufacturer of Active Pharmaceutical Ingredient (API) products in the Anti - Diabetic, Anti - Hypertension and Anti - Infectives Therapeutic categories catering to both the Indian domestic as well as rest of the world (ROW) markets, with clients spanning across Asia, Americas, and Africa.
It has 2 manufacturing facilities in Solapur, India. The Company set up a plant at Solapur, Maharashtra, to manufacture bulk drugs like diloxanide furoate (inst. cap. : 24 tpa) and sulphadiazine (inst. cap. : 36 tpa).
It expanded its activities and product range in 1993-94 by manufacturing metronidazole benzoate, tinidazole, paracetamol and norfloxacin.

FAQs for the comparison of Lincoln Pharmaceuticals Ltd and Smruthi Organics Ltd

Which company has a larger market capitalization, Lincoln Pharmaceuticals Ltd or Smruthi Organics Ltd?

Market cap of Lincoln Pharmaceuticals Ltd is 1,366 Cr while Market cap of Smruthi Organics Ltd is 132 Cr

What are the key factors driving the stock performance of Lincoln Pharmaceuticals Ltd and Smruthi Organics Ltd?

The stock performance of Lincoln Pharmaceuticals Ltd and Smruthi Organics Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Lincoln Pharmaceuticals Ltd and Smruthi Organics Ltd?

As of May 5, 2026, the Lincoln Pharmaceuticals Ltd stock price is INR ₹682.1. On the other hand, Smruthi Organics Ltd stock price is INR ₹116.05.

How do dividend payouts of Lincoln Pharmaceuticals Ltd and Smruthi Organics Ltd compare?

To compare the dividend payouts of Lincoln Pharmaceuticals Ltd and Smruthi Organics Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.